- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 101 John F Kennedy Parkway Short Hills NJ United States of America 07078
- IPO Date
- Oct 31, 1996
- Business
- Franklin Mutual Shares Fund (TESIX) is an open-end mutual fund managed by Franklin Mutual Advisers, LLC, a subsidiary of Franklin Resources, Inc., that seeks capital appreciation, which may occasionally be short term, with income as a secondary objective. The fund pursues its goals through a value-oriented investment strategy focused on undervalued mid- and large-cap equity securities of U.S. and foreign companies; special situations including distressed securities and merger arbitrage positions; and a diversified mix across asset classes such as U.S. stocks (approximately 80.70%), non-U.S. stocks (11.32%), and cash equivalents (5.03%), with top sector allocations in pharmaceuticals, biotechnology & life sciences (10.96%), capital goods (8.23%), banks (8.10%), financial services (6.72%), and consumer discretionary distribution & retail (6.06%). It maintains a concentrated portfolio of 59 issuers with total net assets of $6.97 billion, a weighted average market capitalization of $340.58 billion, and valuation metrics including a price-to-book ratio of 2.71x, price-to-earnings of 17.96x (12-month trailing), and dividend yield of 1.97%, benchmarking against the Russell 1000 Value Index. Originally launched in 1949 as part of the Franklin Mutual Series funds, TESIX represents the Class A share class (inception November 1, 1996; CUSIP 628380602), with operations centered in Short Hills, New Jersey, under Franklin Templeton, headquartered in San Mateo, California. In recent developments, the fund has been managed by the current team since 2020, with ongoing adjustments noted in 2025 market commentary highlighting stock selection contributions from Ferguson Enterprises, Flex, and Johnson Controls International amid U.S. equity rallies driven by tariff policy shifts and interest-rate cut expectations, alongside detractors like Fiserv, Global Payments, and Zimmer Biomet Holdings; portfolio allocation as of November 30, 2025, emphasizes 92.63% in undervalued equities and 6.14% in special situations. Franklin Templeton issued value-focused insights throughout 2025, including the December 1 Global Value Outlook projecting stronger international value performance into 2026, and earlier pieces on broken growth stocks, smaller company recoveries, and European value drivers, reflecting strategic emphasis on fundamental research amid trade uncertainties and consumer spending pullbacks.